magAssist Recognized in 2024 VENTURE50 Awards

Thrilled to announce that magAssist has been named to the TOP50 and Healthcare TOP50 in the prestigious 2024 VENTURE50 rankings by Zero2IPO Group and the Investment Community!

The VENTURE50 is a renowned benchmark, one of the most highly regarded awards in the startup ecosystem in China, highlighting high-growth, innovative companiesr with global potential across sectors like Deep Tech, AI, Healthcare, and Clean Energy. Since 2006, it has been a key platform for identifying industry disruptors with exceptional potential.

This recognition is a testament to magAssist’s dedication to advancing cardiac care. Our innovations are designed to fill critical gaps, save lives, and give hope to patients worldwide. We’re also committed to sustainable, accessible, and responsible medical solutions that benefit both people and the planet.

A huge thank you to our team, partners, and investors for being part of this incredible journey. Together, we’re shaping the future of cardiac care!